Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06095154 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Study description shortened, about 3 words
    v4
  2. Primary completion date: Jan 1, 2025 to Dec 31, 2027v3 Show 7 more changesShow less
    • Start date: Jan 1, 2024 to Jan 1, 2025
    • Enrollment target: 454 to 474
    • Study completion date: Jan 1, 2027 to Dec 31, 2030
    • Interventions: New-mode reduce-volume target IMRT (Radiation) to CTV Delineation Based on Geometric Expansion From GTV in Nasopharyngeal Carcinoma (Radiation)
    • Secondary endpoints expanded, about 10 words
    • Study description expanded, about 175 words
    • Study title expanded, about 4 words
  3. Phase: Not applicable to Phase 3
    • Enrollment target: 100 to 454
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The aim of this study is to evaluate the efficacy and safety of modified IMRT, of which CTV delineation was only based on geometric expansion from GTV.
Trial Details
NCT Number NCT06095154
Lead Sponsor Fujian Cancer Hospital
Conditions
(from sponsor)		 Nasopharyngeal Carcinoma by AJCC V8 Stage
Enrollment 474 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov